Objectives: to compare and evaluate the effectiveness of extracorporeal shock wave therapy (ESWT) and low-level laser therapy (LLLT) using diagnostic ultrasound (US) in the management of chronic plantar fasciitis (PF). Patients and Methods: The study was done as a prospective, randomized, comparative clinical study. Patients with PF were randomly allocated into 2 groups: ESWT (n= 23), LLLT (n= 23), group 1 underwent 2 sessions of ESWT (2050 shocks, 2.5 bars) and group 2 underwent 6 sessions of LLLT (27 J/cm2; 830 nm). All patients were assessed using the visual analog scale (VAS), foot function index (FFI) and diagnostic US to measure plantar fascia thickness and to assess echogenicity before and 1 month after treatment. Results: There were significant improvement after one month of treatment in the mean VAS, FFI, thickness of the plantar fascia and echogenicity in both groups. LLLT proved significantly superior to ESWT in pain relief (p = 0.029), but no significant difference between both groups in FFI improvement (p= 0 .264). No statistically significant difference between both groups regarding improvement in US findings including plantar fascia thickness (p= 0.885) and echogenicity (p= 0.34). Conclusion: LLLT proved to be more effective than ESWT in pain relief in patients with PF after one month of treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.